Topic: Lantus
LONDON (Reuters) - A Swedish study has rekindled concerns about a possible link between Sanofi's top-selling insulin drug Lantus and cancer, but the French drugmaker said on Wednesday the observational research was seriously flawed.It said separate data would be presented on ...
PARIS (Reuters) - French drugmaker Sanofi said a late-stage study of its lixisenatide drug in combination with Lantus insulin showed a significant improvement in blood sugar levels and a beneficial effect on body weight in type 2 diabetes patients.Lixisenatide, which will be ...
NEW YORK (Reuters) - Sanofi SA's chief executive has already put his company's patent expiration woes in the rear view mirror and believes that the French drugmaker and the pharmaceutical industry are undervalued."We're not in a market that's ...
Sanofi SA (SNY, SAN. FR) Monday announced data that demonstrates that initiating Lantus in type 2 diabetes patients leads to better glycemic...
SAN DIEGO (Reuters) - Obesity and longevity have helped make diabetes an epidemic in much of the world, and drugmakers are jockeying to make sure their medicines are used early and often.Companies including Sanofi and Eli Lilly aim to introduce new classes ...
Executives. . Matthew Pfeffer - Chief Financial Officer, Principal Accounting Officer and Corporate Vice President. . Alfred Mann - Founder...
Novo Nordisk (NVO) could not have done much more in its quest to prove that degludec, its new long-lasting insulin, is better than Sanofi-Aventis's...
Danish pharmaceutical company Novo Nordisk said Thursday it planned to put a new insulin product on the market by 2013 after tests showed advantages to the widely sold diabetes drug Lantus."We believe that this ultra long-acting fourth-generation insulin will be a ...
Acetazolamide, or Diamox, is a prescription medication used for some types of epilepsy, fluid buildup or glaucoma. Look for health problems like kidney disease or liver disease. Pay attention to the medications the patient is currently taking. com, Topamax, Xanax, Prozac, Azopt ...
Last week, Sanofi-Aventis (SNY) confirmed that it is on the prowl for diabetes partnerships. Bloomberg reported statements made by Riccardo...
